Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07099716

OBPM_HARMONY: Physiological Data Recording Over 24 Hours Using the Continual Optical Hilo Blood Pressure Monitor and an Ambulatory Blood Pressure Monitor

The OBPM_HARMONY study will enroll a minimum of 300 participants at the CHUV site in Lausanne, Switzerland. Each participant will complete two study visits at CHUV, scheduled at least 24.5 hours apart. Between these visits, participants will be asked to wear both the Hilo band, an Ambulatory Blood Pressure Monitor (ABPM) as well as a hydrostatic pressure system continuously for a 24-hour period.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

21 year–85 year

Sex eligibility

All sexes

Study type

Observational

About this study

The OBPM_HARMONY study will enroll a minimum of N= 300 participants. Each participant will complete two visits at the CHUV site in Lausanne, Switzerland: Visit 1 (~40 minutes) and Visit 2 (~15 minutes), spaced at least 24.5 hours apart. During Visit 1, participants are equipped with three devices- the Device Under Test (Hilo band), the reference device (Ambulatory Blood Pressure Monitor), worn on the opposite arm, and a hydrostatic pressure system on the chest. Subjects are instructed to wear the three devices for the next 24 hours to collect blood pressure (BP) and heart rate (HR) data, as well as hydrostatic pressure measurements. After Visit 1, subjects return home with the devices in place. Visit 2 takes place at least 24.5 hours later, when participants return to the site to hand back the equipment and complete a feedback survey regarding their experience using the Hilo band and the ABPM reference.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects aged 21 to 85yo
  • Subjects fluent in written and spoken French, capable of discernment
  • Subjects agreeing to attend the two study visits and follow study procedures
  • Subjects residing within 100 km of the CHUV site
  • Subjects that have signed the informed consent form.

Exclusion criteria

  • Damaged/injured skin at the right wrist
  • Subjects with tachycardia (heart rate at rest > 120bpm)
  • Subjects with atrial fibrillation
  • Subjects with diabetes
  • Subjects with marked renal dysfunctions
  • Subjects with untreated hyper-/hypothyroidism
  • Subjects with pheochromocytoma
  • Subjects with Raynaud's disease
  • Subjects with an arteriovenous fistula
  • Subjects with implanted electrical devices, such as cardiac pacemakers or defibrillators
  • Subjects with premature ventricular beats
  • Subjects with peripheral arterial disease
  • Subjects undergoing intravascular therapy or arterio-venous shunt
  • Subjects who have received a mastectomy
  • Women in known pregnancy or women with pre-eclampsia
  • Subjects of unsound mind
  • Subjects with upper arm circumference < 22cm or > 42cm
  • Subjects with wrist circumference <14cm or > 23cm
  • A lateral difference in systolic blood pressure >15 mmHg or diastolic blood pressure >10 mmHg between arms.

Treatment and study plan

Wearing Hilo band, Ambulatory Blood Pressure Monitor, and Hydrostatic Pressure monitor

Device

During study Visit 1, participants are equipped with tthree devices- the Device Under Test (Hilo band), the reference device (Ambulatory Blood Pressure Monitor), worn on the opposite arm, and a Hydrostatic pressure monitor on the chest. Subjects are instructed to wear the three devices for the next 24 hours to collect blood pressure (BP) and heart rate (HR) data as well as hydrostatic pressure measurements. After Visit 1, subjects return home with the devices in place. Visit 2 takes place at least 24.5 hours later, when participants return to the site to hand back the equipment.

Primary outcomes

  1. Raw 24-hour data collection using the continual Hilo monitor alongside the Ambulatory Blood Pressure Monitor across minimum 300 study subjects.

    Time frame: 24 hours

Secondary outcomes

  1. Evaluation of survey results on comfort, usability, and ease of use for both devices

    Time frame: 24 hours

Study contacts

Contact information is provided by the study sponsor or research team.

Grégoire WUERZNER, Prof. Med.

CONTACT

[email protected]

+41 21 314 02 23

Sponsors and collaborators

Lead sponsor

Aktiia SA

Industry

Registry information

Official study title

Physiological Data Recording Over 24 Hours Using the Continual Optical Hilo Blood Pressure Monitor and an Ambulatory Blood Pressure Monitor: a Single-center, Prospective Clinical Study.

Acronym: OBPM_HARMONY

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Aug 1, 2025
Registry last updated
Sep 12, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.